British Medical Association Accepts Cass Review of Gender Identity Services

In a significant development, the British Medical Association (BMA), the trade union representing doctors across the UK, has withdrawn its opposition to the Cass review of gender identity services within the NHS.

The BMA had initially rejected the findings of the review, which was conducted by Dr. Hilary Cass and published in April 2024. The review examined transgender healthcare services and concluded that children and young people had been let down due to a lack of research and evidence on medical interventions. It also stated that NHS gender medicine was built on 'shaky foundations'.

However, in a recent turn of events, the BMA's council has voted to accept the review's findings, acknowledging the robustness of its methodology. Prof David Strain, who led the BMA's review, stated that the Cass report's methodology was sound and that the BMA no longer opposes any of its 32 recommendations.

The BMA's review, conducted by 12 union members, highlighted the importance of constructive engagement between clinicians with differing perspectives. This collaborative approach ensured that the concerns of both the medical profession and individuals with lived experience were thoroughly explored.

While the BMA's report largely aligns with the Cass review's findings, the union raised concerns about some of the government's actions following the review. They specifically mentioned the ban on puberty blockers on the NHS, which they believe goes beyond Cass's recommendations. The union emphasized the importance of medical autonomy and the potential negative impact of political decisions on prescribing practices.

A crucial aspect of the Cass review was its finding that there was no evidence to support prescribing sex hormones to under-18s. The review also shed light on the complex needs of young people, including trauma, self-harm, and depression, which were sometimes not adequately addressed before medical treatment.

As a consequence of the Cass review, the Tavistock clinic in London, the UK's only NHS gender identity development service, was closed in March 2024. This service had treated approximately 9,000 children and young people between 2009 and 2020, with an average referral age of 14.

The BMA's acceptance of the Cass review marks a positive step towards improving gender identity services within the NHS, emphasizing the importance of evidence-based practices and patient-centered care.